Utama › Penyakit Alzheimer › Pennsylvania › Philadelphia
Kajian klinikal Penyakit Alzheimer di Philadelphia, PA
15 kajian untuk Penyakit Alzheimer sedang mencari peserta di lokasi dalam dan sekitar Philadelphia (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease
Mengambil pesertaFasa 2
- Flourish Research - Keystone Clinical Studies- Site Number : 8400003, Plymouth Meeting · 12 mi jauh
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Mengambil pesertaFasa 2
- Pennsylvania Hospital, Philadelphia
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Mengambil pesertaFasa 3
- Flourish Research ? Philadelphia, Plymouth Meeting · 12 mi jauh
PET Imaging Tau Accumulation in FTLD and Atypical Alzheimer's Using [18F]-PI-2620
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- Perelman Center for Advance Medicine, Philadelphia
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Mengambil pesertaFasa 3
- Keystone Clinical Studies, Plymouth Meeting · 12 mi jauh
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
Mengambil peserta
- Hospital of the University of Pennsylvania, Philadelphia
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
Mengambil pesertaKajian pemerhatian
- University of Pennsylvania, Philadelphia
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
Mengambil pesertaFasa 2
- Thomas Jefferson University - Vickie & Jack Farber Institute for Neuroscience, Philadelphia
Biofluid Research on Age-Related or Inherited Neurodegeneration
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Pennsylvania, Philadelphia
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
Mengambil pesertaFasa 2
- Flourish Research ( Site 1048), Plymouth Meeting · 12 mi jauh
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
Mengambil peserta
- Penn Medicine, Philadelphia
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Mengambil pesertaFasa 3
- Penn Presbyterian Medical Center, Philadelphia
A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease
Mengambil pesertaFasa 2
- Abington Neurological Associates Ltd, Willow Grove · 13 mi jauh
UPenn Observational Research Repository on Neurodegenerative Disease
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- University of Pennsylvania, Philadelphia
Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
Mengambil pesertaFasa awal 1
- University of Pennsylvania, Philadelphia
Kajian Penyakit Alzheimer di bandar lain
- Boston, MA26 kajian
- Orlando, FL25 kajian
- St. Louis, MO22 kajian
- New York City, NY21 kajian
- Miami, FL20 kajian
- Tampa, FL17 kajian
- Atlanta, GA16 kajian
- The Villages, FL15 kajian
- Phoenix, AZ15 kajian
- Indianapolis, IN14 kajian
- Los Angeles, CA14 kajian
- West Palm Beach, FL13 kajian
Kajian lain di Philadelphia
- Kanser (semua jenis)59 kajian
- Kanser Payudara56 kajian
- Kanser Paru-paru Bukan Sel Kecil51 kajian
- Kanser Metastatik46 kajian
- Kanser Prostat44 kajian
- Kanser Kolorektal44 kajian
- Kanser Ovari44 kajian
- Kanser Paru-paru36 kajian
- Leukemia Mieloid Akut34 kajian
- Kegagalan Jantung31 kajian
- Kanser Endometrium28 kajian
- Depresi26 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.